ASX BRIEFS

Send us Fan Mail A single drill intercept can change the whole story, especially when it challenges the idea that a deposit should “pinch out” with depth. We’re joined by Tim Fraser, General Manager at Evergold Minerals Limited, to break down what’s happening at the Mount Monger gold project in Western Australia and why the latest result at Duchess of York (22 metres at 1.8 g/t gold) is such a mea...

Send us Fan Mail A defence supply chain crunch is forcing a rethink: what if you could manufacture certified metal parts closer to the shipyard, the depot, or even the operational edge, instead of waiting on long, fragile supplier queues? We sit down with Sean Ebert, CEO of AML3D Limited, to unpack how large-scale additive manufacturing and 3D metal printing are being put to work right now, not as...

Send us Fan Mail MSA is rare, relentless, and too often diagnosed only after the most obvious neurological symptoms arrive. We’re joined by David Stamler, Managing Director and CEO of Alterity Therapeutics, to explain what multiple system atrophy can look like from the first vague signs through to rapid loss of mobility, and why symptomatic treatments leave such a large unmet need.  We talk throug...

Send us Fan Mail Cement and steel making doesn't just burn fuel, CO₂ is also released as part of the process. That’s why industrial decarbonisation is so hard, and why a “just electrify it” slogan falls short once you get into kilns, furnaces, and process emissions. We’re joined by Phil Hodgson, Managing Director and CEO of Calix Limited, to break down an Australian-developed platform technol...

Send us Fan Mail Silica dust does not care about good intentions, and neither do regulators. We sit down with Gabrielle O’Carroll, CEO of Sydney-based CleanSpace Holdings Ltd, to unpack how respiratory protection is evolving as workplaces face tighter exposure limits, stronger enforcement, and rising expectations across mining, construction, quarrying and manufacturing. We start with the core prob...

Send us Fan Mail A security monitoring business doesn’t grow a $63.2m secured installation pipeline by accident, so we sat down with Dennison Hambling, Managing Director of Intelligent Monitoring Group (IMG), to understand what’s really driving the momentum. We talk candidly about why large enterprises across Australia and New Zealand are increasingly choosing a single national provider for electr...

Send us Fan Mail A marketplace can tell you more about the economy than a headline number, especially when thousands of everyday jobs are priced in real time. We sit down with Tim Fung to break down Airtasker’s Q3 performance and what’s really driving momentum in Australia: rising job volumes, strong completion rates, and an uplift in average task prices that reflects both demand and the cost-of-l...

Send us Fan Mail “Recycled” sounds simple until you ask one awkward question: what exactly was recycled to make this product? We’re joined by Marie De Perthuis, CEO of MyEco Group Limited, to talk about how sustainable packaging earns trust when greenwashing is everywhere and shoppers are time-poor at the shelf. We get a clear view of MyEco Group’s model: a Melbourne-based brand with manufacturing...

Send us Fan Mail A small ASX biotech can feel impossible to value until the data starts landing, and that’s exactly where Syntara is headed. We’re joined by CEO Gary Phillips to map out a tight run of clinical catalysts and the thinking behind a pipeline built around extracellular matrix dysfunction and amine oxidase chemistry, backed by specialist institutional investors and real in-house drug di...

Send us Fan Mail A medical device can be brilliantly engineered and still fail for one simple reason: it never makes it from regulatory clearance to routine use in hospitals. We talk with Paul Anderson, CEO and Managing Director of Orthocell Limited, about how his team is trying to close that gap with a collagen-based regenerative medicine platform designed to support repair of bone, nerve and ten...

Send us Fan Mail A kids smartwatch can be a solid business. A family safety platform that telcos can deploy to millions of customers is a very different ambition, and that’s what we explore with Simon Crowther, CEO and Managing Director of Spacetalk Limited (ASX: SPA). We start with the core product that built the Spacetalk brand: a kids safety smartwatch that gives parents peace of mind through l...

Send us Fan Mail The EV battery revolution isn’t just about who sells the most cars, it’s about who controls the materials that make batteries cheaper, safer, and easier to source. I’m joined by Ron Mitchell, CEO of Firebird Metals, to talk about a different kind of advantage: taking manganese concentrate and turning it into high value battery materials in a single integrated processing circuit, r...

Send us Fan Mail Mine sites are drowning in tasks that are repetitive, risky, and time-heavy, yet the real value sits on the other side of the work: clean data that helps people make faster calls. We chat with Chris Clark, Managing Director and CEO of RocketDNA Limited, about how AI-driven autonomous drones are taking on aerial surveying, security and surveillance, and asset inspection for Tier 1...

Send us Fan Mail A fintech business can grow fast, but growing efficiently is the real test. We sit down with Mark Waller, Managing Director of One Click Group Limited, for a clear update on how One Click Life is scaling as a financial life admin app for Australians. Mark walks us through the company’s FY2025 performance, including record revenue of $6.1 million and its first underlying EBITDA pro...

Send us Fan Mail A thin, high-grade reef can be impressive on paper, but it can also be hard to mine at scale. That’s why we sit down with GreenTech Metals CEO James Rattenbury to talk about a different way to view the Munni Munni platinum group metals system in Western Australia’s West Pilbara: not just the reef, but the wider mineralised zones around it that bring copper and nickel into the stor...

Send us Fan Mail One obscure material is quietly doing heavy lifting across the modern economy: high purity alumina (HPA). From LED lighting to semiconductor manufacturing to the thermal management challenges inside fast-growing data centres, HPA shows up where heat and chemical stability can’t be left to chance. We sit down with Dr Mike Jones, Managing Director of Impact Minerals, to break down w...

Send us Fan Mail A rare earth project that aims to get to production without crushers, grinding circuits, or a high-cost processing maze gets our attention fast. We sit down again with Andrew Reid, Managing Director of Brazilian Critical Minerals (ASX: BCM), to unpack the Ema ionic adsorption clay deposit in Brazil and why in situ recovery (ISR) could be a genuine cost and schedule advantage for a...

Send us Fan Mail A pen-sized microscope that can see living tissue in real time sounds like science fiction, but it’s exactly what Optiscan Imaging Limited is building. We welcome back Dr Camile Farah to talk through the company’s confocal laser endomicroscopy platform and why real-time digital pathology could change the way surgery, cancer care, and veterinary medicine make decisions at the point...

Send us Fan Mail A product can be ready for the world and still be held back by one thing: how regulators choose to classify it. We sit down again with Dr Peter Molloy, Executive Chairman of Firebrick Pharma, to unpack the company’s shift from R&D to commercial execution and why a single regulatory milestone in Indonesia changes the scale of the Nasodine opportunity. Peter walks us through the...

Send us Fan Mail A scan that finds brain metastases earlier could change the whole treatment timeline, and that is exactly what we dig into with Riccardo Canevari, CEO and Managing Director of Radiopharm Theranostics. We walk through how a clinical-stage ASX biopharmaceutical company designs radiopharmaceuticals for oncology, and why “theranostics” is more than a buzzword when patients need faster...

Send us Fan Mail Five complete responses in advanced pancreatic cancer should make anyone in biotech sit up. We’re joined by Dr Chris Burns, CEO and Managing Director of Amplia Therapeutics, to unpack what the latest mature ACCENT trial data really says about narmafotinib when it’s added to standard chemotherapy with gemcitabine and Abraxane and why “making other drugs work better” is more than a...

Send us Fan Mail A junior explorer doesn’t often get the chance to step into prime ground that’s already been stress-tested by a major miner, right in the middle of a proven hard-rock lithium district. That’s why we sat down with Mitch Thomas, CEO of Solis Minerals, to unpack Solis’ strategic acquisition from Rio Tinto in Brazil’s Lithium Valley and what a 93,000 hectare land position can really m...

Send us Fan Mail Guinea supplies a huge share of the traded bauxite market and that concentration is forcing buyers and investors to rethink supply security. We sit down with Ryan De Franck, Managing Director of VBX Limited, to unpack why the Wuudagu Bauxite Project in Western Australia’s North Kimberley could stand out in the global bauxite landscape through a simple idea: pair high-grade, low-si...

Send us Fan Mail A kid can’t learn well if the world sounds muffled, painful, or simply out of reach. We’re joined by Dr James Fielding, Managing Director and CEO of Audeara Limited, to talk through a pivotal stretch for this ASX-listed hearing health technology and audio technology company, following strong Q3 FY26 results and a growing global footprint. We start with what Audeara actually builds...

Send us Fan Mail Electrification gets most of the headlines, but what happens when an industry needs constant high-temperature heat and the equipment is built for gas? That’s where biomethane and renewable gas infrastructure start to look less like a niche and more like a missing piece of Australia’s decarbonisation plan. We’re joined by Joe Oliver, Managing Director of Delorean Corporation Limite...